Guest Columns
-
5 Foundations Of Lean Leadership For Pharmaceutical & Medical Device Professionals
7/2/2021
Every life sciences company, now more than ever before, is on a journey to provide greater returns to stakeholders by manufacturing products at better quality and lower cost, which is the aim of lean manufacturing. However, many people forget about the cultural and leadership aspects of lean, which at its foundation are responsible for the success or failure of a lean transformation.
-
Digital Health Technologies: The Evolving Landscape Of Reimbursement & 4 Strategies To Consider
6/30/2021
The use of digital health technologies (DHTs), ranging from devices and apps to cloud-based services and artificial intelligence platforms, has accelerated rapidly in recent years. But there are issues in funding, which hinders innovation. This analysis sheds light on the situation and offers 4 strategies for manufacturers to consider.
-
Emerging Technologies In The Delivery Of Proteins & Peptides
6/28/2021
The limited ability to selectively deliver new drug molecules in the forms of peptides and proteins remains a significant challenge. Therefore, new materials and manufacturing techniques are emerging to meet the challenges associated with the formulation and delivery of biopharmaceuticals and pharmaceuticals.
-
Shorten Your Medical Device Development Timeline Using These 3 Design Research Strategies
6/23/2021
Design research can shorten the development process by making your FDA submission quicker and easier. Plus, you are making it more robust by doing the work now as opposed to later. Too many people wait until later in the process for this work and end up guessing on things or adding “filler” to their usability data. This article recommends three design research strategies.
-
Data Integrity In Supply Chain Risk Management During Zero Trust
6/21/2021
Due to the pandemic, we have had to reconsider our approaches to supply chain risk management and to develop new and creative risk management strategies and tactics in response. This article examines how data integrity principles mitigate ALCOA concerns during this period of zero trust.
-
Medtech In Chile: Currently Latin America’s Easiest Market, But For How Long?
6/16/2021
The total market size of the medical device sector in Chile is about $1.7 billion and has grown a whopping 75 percent since 2017. The nation imports most of its medical devices, and it currently has the easiest regulatory hurdles for medtech in Latin America. However, you should prepare for the upcoming bill that may impact regulation.
-
7 Key Strategies For An Effective Commercial Training Program
6/14/2021
Robust training and education programs play an important role in ensuring seamless adoption and implementation for any new product. As a manufacturer, you must consider these 7 key takeaways when developing, assessing, or redesigning a commercial training program.
-
The “Resiliency Roadmap” — Next Steps For FDA Inspections
6/11/2021
More than a year into the COVID-19 pandemic and FDA’s abrupt suspension of on-site inspections in March 2020, the agency released the Resiliency Roadmap for FDA Inspectional Oversight in May 2021. This article examines how this news affects the pharmaceutical, biotech, and medical device industries.
-
The Evolution Of Telehealth: What’s Next For Medical Device Companies?
6/9/2021
Telehealth was 2020’s breakout star. Over the last five years, we have witnessed a marked shift in payer, provider, and patient perspectives regarding telehealth and, more specifically, telehealth-related medical devices. This article shares key insights into these perspectives and how medical device companies can penetrate the market successfully.
-
Meet Hearables, The Next Revolutionary Medical Devices
6/7/2021
Hearables, in-ear devices that use sensors to monitor health, are poised to become the next revolutionary technology. Jacob Skinner, CEO of U.K.-based wearable technology design and development consultants Thrive Wearables, discusses its possibilities.